Average Insider

Where insiders trade, we follow

Dyne Therapeutics, Inc. ($DYN)
Accession: 0001577014-26-000004
Apr 27, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$8.06
Current$18.1659.6% above low, 40.4% below high
52W High$25.00

Filing Information

Accession Number0001577014-26-000004
Form Type4
Filing DateApr 27, 2026
DocumentView SEC Filing
Transactions
12
Total Shares
384,549
Total Value
$7,101,119.51

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Rhodes Jason P
Director
Common Stock
โ€”Apr 23, 2026Sale19,261$19.19$369,618.591,719,356IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 23, 2026Sale38,322$19.19$735,399.185,221,857IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 23, 2026Sale377$19.19$7,234.6311,286IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 23, 2026Sale15,148$19.19$290,690.121,270,556IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 24, 2026Sale36,345$18.48$671,655.601,683,011IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 24, 2026Sale72,310$18.48$1,336,288.805,149,547IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 24, 2026Sale710$18.48$13,120.8010,576IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 24, 2026Sale28,583$18.48$528,213.841,241,973IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 27, 2026Sale45,709$18.15$829,618.351,637,302IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 27, 2026Sale90,943$18.15$1,650,615.455,058,604IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 27, 2026Sale894$18.15$16,226.109,682IndirectSee footnoteView Details
Rhodes Jason P
Director
Common Stock
โ€”Apr 27, 2026Sale35,947$18.15$652,438.051,206,026IndirectSee footnoteView Details
Version: v26.3.33